MoneyWorks4Me

Samrat Pharmachem - Quaterly Results

14 Aug 2023 Evaluate
The sales is pegged at Rs. 575.00 millions for the June 2023 quarter. The mentioned figure indicates a decline of about -33.53% as against Rs. 865.01 millions during the year-ago period.Net Profit for the quarter ended June 2023 dipped to Rs. 6.11  millions from Rs. 93.67 millions  in the corresponding previous quarter.Operating profit for the quarter ended June 2023 decreased to 11.35 millions as compared to 129.11 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 575.00 865.01 -33.53 575.00 865.01 -33.53 3106.46 2217.51 40.09
Other Income 3.44 0.31 1009.68 3.44 0.31 1009.68 4.78 6.33 -24.49
PBIDT 11.35 129.11 -91.21 11.35 129.11 -91.21 244.06 248.70 -1.87
Interest 2.20 2.26 -2.65 2.20 2.26 -2.65 12.32 6.74 82.79
PBDT 9.15 126.85 -92.79 9.15 126.85 -92.79 231.74 241.96 -4.22
Depreciation 1.62 1.58 2.53 1.62 1.58 2.53 6.43 5.95 8.07
PBT 7.53 125.27 -93.99 7.53 125.27 -93.99 225.31 236.01 -4.53
TAX 1.42 31.60 -95.51 1.42 31.60 -95.51 59.00 64.16 -8.04
Deferred Tax -0.49 0.31 -258.06 -0.49 0.31 -258.06 -2.07 0.28 -839.29
PAT 6.11 93.67 -93.48 6.11 93.67 -93.48 166.31 171.85 -3.22
Equity 30.90 30.90 0.00 30.90 30.90 0.00 30.90 30.90 0.00
PBIDTM(%) 1.97 14.93 -86.78 1.97 14.93 -86.78 7.86 11.22 -29.95
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..